2023
DOI: 10.1200/po.22.00378
|View full text |Cite
|
Sign up to set email alerts
|

Pediatric Rectal Adenocarcinoma With Mismatch Repair Deficiency Responds to Immunotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 20 publications
0
1
0
Order By: Relevance
“…11 However, to date, data for neoadjuvant immunotherapy are scarce, mainly due to the rarity of such tumours in children and adolescents. In adult patients, neoadjuvant immunotherapy of patients with localised MSI-h/dMMR CRC led to excellent treatment responses in two major phase 3 trials.…”
mentioning
confidence: 99%
“…11 However, to date, data for neoadjuvant immunotherapy are scarce, mainly due to the rarity of such tumours in children and adolescents. In adult patients, neoadjuvant immunotherapy of patients with localised MSI-h/dMMR CRC led to excellent treatment responses in two major phase 3 trials.…”
mentioning
confidence: 99%